Frans Rutten
Frans Rutten
Professor of Health Economics
bmg.eur.nl üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
The friction cost method for measuring indirect costs of disease
MA Koopmanschap, FFH Rutten, BM van Ineveld, L Van Roijen
Journal of health economics 14 (2), 171-189, 1995
13721995
Costs, effects and C/E‐ratios alongside a clinical trial
BA Van Hout, MJ Al, GS Gordon, FFH Rutten
Health economics 3 (5), 309-319, 1994
10331994
Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria
S Evers, M Goossens, H De Vet, M Van Tulder, A Ament
International journal of technology assessment in health care 21 (2), 240-245, 2005
6522005
Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis
AJ Goverde, J McDonnell, JPW Vermeiden, R Schats, FFH Rutten, ...
The lancet 355 (9197), 13-18, 2000
5382000
Equity in the finance and delivery of health care: an international perspective
E Doorslaer, A Wagstaff, F Rutten
Oxford University Press, 1992
5211992
Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report
M Drummond, M Barbieri, J Cook, HA Glick, J Lis, F Malik, SD Reed, ...
Value in health 12 (4), 409-418, 2009
4732009
Standardisation of costs
JB Oostenbrink, MA Koopmanschap, FFH Rutten
Pharmacoeconomics 20 (7), 443-454, 2002
4512002
A practical guide for calculating indirect costs of disease
MA Koopmanschap, FFH Rutten
Pharmacoeconomics 10 (5), 460-466, 1996
4161996
Welfarism vs. extra-welfarism
WBF Brouwer, AJ Culyer, NJA van Exel, FFH Rutten
Journal of health economics 27 (2), 325-338, 2008
4032008
Labor and Health Status in Economic Evaluation of Health Care: The Health and Labor Questionnaire
L Van Roijen, ML Essink-Bot, MA Koopmanschap, G Bonsel, FFH Rutten
International journal of technology assessment in health care 12 (3), 405-415, 1996
3581996
Productivity losses without absence: measurement validation and empirical evidence
WBF Brouwer, MA Koopmanschap, FFH Rutten
Health policy 48 (1), 13-27, 1999
2701999
Costing in economic evaluations
W Brouwer, F Rutten, M Koopmanschap
Economic evaluation in health care: merging theory with practice. Oxford …, 2001
2572001
Need for differential discounting of costs and health effects in cost effectiveness analyses
WBF Brouwer, LW Niessen, MJ Postma, FFH Rutten
Bmj 331 (7514), 446-448, 2005
2482005
Comparing methodologies for the cost estimation of hospital services
SS Tan, FFH Rutten, BM Van Ineveld, WK Redekop, ...
The European Journal of Health Economics 10 (1), 39-45, 2009
2452009
Productivity costs measurement through quality of life? A response to the recommendation of the Washington Panel
WBF Brouwer, MA Koopmanschap, FFH Rutten
Health Economics 6 (3), 253-259, 1997
2391997
Economic valuation of informal care: lessons from the application of the opportunity costs and proxy good methods
B Van den Berg, W Brouwer, J van Exel, M Koopmanschap, ...
Social science & medicine 62 (4), 835-845, 2006
2182006
The evidence-based approach in health policy and health care delivery
LW Niessen, EWM Grijseels, FFH Rutten
Social science & medicine 51 (6), 859-869, 2000
2102000
Indirect costs in economic studies
MA Koopmanschap, FFH Rutten
Pharmacoeconomics 4 (6), 446-454, 1993
2051993
The role of economic evaluation in the pricing and reimbursement of medicines
M Drummond, B Jönsson, F Rutten
Health policy 40 (3), 199-215, 1997
1971997
Caring for and caring about: disentangling the caregiver effect and the family effect
A Bobinac, NJA Van Exel, FFH Rutten, WBF Brouwer
Journal of health economics 29 (4), 549-556, 2010
1952010
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20